Haloperidol antagonism of cue-elicited cocaine craving

被引:150
作者
Berger, SP
Hall, S
Mickalian, JD
Reid, MS
Crawford, CA
Delucchi, K
Carr, K
Hall, S
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143
[2] PACIFIC MED CTR,DEPT PSYCHIAT,SAN FRANCISCO,CA
[3] VET AFFAIRS MED CTR,SAN FRANCISCO,CA 94121
[4] UNIV CALIF LOS ANGELES,BRAIN RES INST,PROGRAM NEUROSCI,LOS ANGELES,CA
关键词
D O I
10.1016/S0140-6736(96)91139-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Studies of cocaine-dependent subjects have shown that re-exposure to environmental cues previously associated with cocaine use produces a strong conditioned response characterised by autonomic hyperarousal and increases in subjective measures of cocaine craving. Methods To evaluate the role of dopamine release by such cues, 20 cocaine-dependent inpatients were randomised in a single-dose, crossover, placebo-controlled design, to haloperidol (4 mg by mouth) and placebo. Plasma homovanillic acid (HVA, a dopamine metabolite), adrenocorticotropic hormone (ACTH), and cortisol were assayed before and after cue exposure, Craving and anxiety were measured before and after cues with visual analogue scales for desire to use cocaine now and for mood changes. Findings Cocaine cues significantly increased anxiety, ACTH, cortisol, and HVA. Increases in anxiety and craving resulting from cue exposure were significantly antagonised by pretreatment with haloperidol. Interpretation It has long been hypothesised that increases in extracellular concentrations of dopamine mediate the acute reinforcing effects of cocaine. Our data suggest that dopamine release may also mediate some of the conditioned responses to cocaine cues.
引用
收藏
页码:504 / 508
页数:5
相关论文
共 26 条
  • [1] HOMOVANILLIC-ACID MEASUREMENT IN CLINICAL RESEARCH - A REVIEW OF METHODOLOGY
    AMIN, F
    DAVIDSON, M
    DAVIS, KL
    [J]. SCHIZOPHRENIA BULLETIN, 1992, 18 (01) : 123 - 148
  • [2] EFFECTS OF ALPRAZOLAM ON PITUITARY-ADRENAL AND CATECHOLAMINERGIC RESPONSES TO METABOLIC STRESS IN HUMANS
    BREIER, A
    DAVIS, O
    BUCHANAN, R
    LISTWAK, SJ
    HOLMES, C
    PICKAR, D
    GOLDSTEIN, DS
    [J]. BIOLOGICAL PSYCHIATRY, 1992, 32 (10) : 880 - 890
  • [3] CHANG WH, 1983, ACTA PHARMACOL TOX, V53, P275
  • [4] Childress A R, 1993, NIDA Res Monogr, V137, P73
  • [5] Childress A R, 1987, NIDA Res Monogr, V76, P137
  • [6] CHILDRESS AR, 1986, BRIT J ADDICT, V81, P655
  • [7] THE EFFECTS OF THE KAPPA-AGONIST U-50,488 ON COCAINE-INDUCED CONDITIONED AND UNCONDITIONED BEHAVIORS AND FOS IMMUNOREACTIVITY
    CRAWFORD, CA
    MCDOUGALL, SA
    BOLANOS, CA
    HALL, S
    BERGER, SP
    [J]. PSYCHOPHARMACOLOGY, 1995, 120 (04) : 392 - 399
  • [8] SINGLE-DOSE BROMOCRIPTINE REVERSES COCAINE CRAVING
    DACKIS, CA
    GOLD, MS
    SWEENEY, DR
    BYRON, JP
    CLIMKO, R
    [J]. PSYCHIATRY RESEARCH, 1987, 20 (04) : 261 - 264
  • [9] FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538
  • [10] CONDITIONED INCREASES IN MESOLIMBIC DOPAMINE OVERFLOW BY STIMULI ASSOCIATED WITH COCAINE
    FONTANA, DJ
    POST, RM
    PERT, A
    [J]. BRAIN RESEARCH, 1993, 629 (01) : 31 - 39